← Evidence map

ArticleBlood2013

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Experts in Chronic Myeloid LeukemiaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

226 papers cite itlatest 60 shown

2013
…
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 23620577